After a steep operating loss in 2024, Repligen delivered a strong rebound to $55.2 million operating income in 2025 supported by robust revenue growth. The company’s liquidity position remains formidable with over $566 million cash and a current ratio of 8.37, reflecting solid short-term financial flexibility. Capital allocation moderated as share repurchases ceased, and capex declined, signaling a more conservative investment stance amid a recovering earnings trajectory.